US · SIBN
SI-BONE, Inc.
- Sector
- Healthcare · Medical - Devices
- Headquarters
- Santa Clara, CA 95050
- Website
- si-bone.com
Price · as of 2025-12-31
$13.21
Market cap 673.43M
Valuation summary
Four models, one snapshot. Upside is target ÷ current − 1.
| Valuation method | Value, $ | Upside, % |
|---|---|---|
| Artificial Intelligence(AI) | $50.02 | +278.65% |
| Intrinsic Value(DCF) | $22.29 | +68.74% |
| Graham-Dodd Method(GD) | $1.91 | -85.56% |
| Graham Formula(GF) | — | — |
Valuation history
Annual price (USD per share) overlaid with each model's fair value. Y-axis is log scale.
| Year | Price | AI | DCF | Graham-Dodd | Graham Formula |
|---|---|---|---|---|---|
| 2011 | |||||
| 2012 | |||||
| 2013 | |||||
| 2014 | $0.00 | $96.67 | |||
| 2015 | $0.00 | $0.00 | |||
| 2016 | $0.00 | $0.00 | |||
| 2017 | $0.00 | $0.00 | |||
| 2018 | $18.80 | $38.26 | $4.46 | $0.18 | $0.00 |
| 2019 | $17.92 | $26.36 | $1.02 | $0.00 | $0.00 |
| 2020 | $31.39 | $36.10 | $4.17 | $0.00 | $0.00 |
| 2021 | $20.20 | $30.70 | $2.13 | $0.00 | $0.00 |
| 2022 | $19.03 | $30.24 | $0.30 | $0.00 | $0.00 |
| 2023 | $17.53 | $40.28 | $28.69 | $0.00 | $0.00 |
| 2024 | $16.06 | $36.42 | $37.94 | $0.30 | $0.00 |
| 2025 | $15.70 | $50.02 | $50.76 | $1.91 | $0.00 |
AI valuation
Our deep-learning model estimates SI-BONE, Inc.'s (SIBN) per-share fair value from quarterly fundamentals, sector trend, and historical valuation patterns.
- AI fair value
- $50.02
- Current price
- $13.21
- AI upside
- +278.65%
Methodology and confidence bands appear in the dedicated valuation theory section. The AI score is an estimate, not a recommendation.
Intrinsic value (DCF)
Open DCF calculatorThree textbook valuation models, recomputed daily from the latest financial statements. The DCF uses our Chepakovich model. Graham-Dodd and Graham Formula are conservative reference points.
DCF
$22.29
+68.74% upside
Graham-Dodd
$1.91
-85.56% upside
Graham Formula
—
— upside
Peer comparison
Same-industry comparables, ranked by market cap.
| Basic Info | Model Valuation | Core Valuation | Profitability | Leverage & Liquidity | Growth | Cash Flow | Dividends | Enterprise Value | Risk | ||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ticker | Company Name | Price | Market Cap | AI Upside | DCF Upside | GD Upside | GF Upside | P/E | P/B | P/S | EV/EBITDA | PEG | P/TBV | Gross Margin | Operating Margin | Net Margin | ROE | ROIC | ROA | Debt/Equity | Interest Coverage | Current Ratio | Quick Ratio | Net Debt/EBITDA | EPS Growth | Sales Growth | FCF Growth | FCF Yield | Op Cash Flow Ratio | Cash ROIC | Dividend Yield | Dividend Payout | Shareholder Yield | EV/EBIT | EV/FCF | EV/Sales | Altman Z-Score |
| SIBN | SI-BONE, Inc. | $13.21 | 673.43M | +279% | +69% | -86% | — | -36.13 | 3.85 | 3.40 | -49.18 | — | 3.85 | 79.57% | -11.11% | -9.41% | -10.97% | -52.40% | -8.06% | 0.01 | -4.23 | 8.55 | 7.03 | 3.77 | -4133.00% | 2019.00% | -6035.00% | -1.33% | -0.03 | -21.33% | 0.00% | 0.00% | 6.39% | -24.02 | -59.01 | 2.67 | 5.57 |
| AIRS | AirSculpt Technologies, I… | $1.58 | 98.65M | +1,797% | -14% | — | — | -23.74 | 2.47 | 1.09 | 29.06 | -30.65 | -4.45 | 60.42% | -1.01% | -4.57% | -10.11% | -1.04% | -3.99% | 1.32 | -0.29 | 0.60 | 0.39 | 9.61 | 7744.00% | -795.00% | -11893.00% | -1.36% | 0.40 | -1.52% | 0.13% | -3.10% | 0.59% | -161.16 | -110.15 | 1.62 | 1.48 |
| AQST | Aquestive Therapeutics, I… | $4.00 | 397.23M | +466% | -73% | — | — | -5.21 | -3.82 | 3.99 | -7.37 | -1.78 | -3.82 | 68.95% | -53.46% | -76.68% | 52.97% | 32.25% | -55.57% | -0.63 | -1.83 | 4.68 | 4.18 | 1.26 | 29231.00% | 1380.00% | 38702.00% | -15.63% | -1.90 | 37.66% | 0.00% | 0.00% | 18.71% | -6.38 | -5.46 | 3.41 | -3.77 |
| AVNS | Avanos Medical, Inc. | $14.10 | 654.51M | +97% | -60% | -93% | — | -8.90 | 0.83 | 0.93 | -20.72 | — | 2.44 | 49.77% | -8.78% | -9.68% | -9.07% | -7.21% | -6.54% | 0.17 | -15.40 | 2.15 | 1.17 | -1.18 | -8288.00% | 195.00% | -4801.00% | 6.64% | 0.45 | 5.05% | 0.00% | 0.00% | 3.58% | -11.17 | 15.96 | 0.98 | 0.98 |
| AVXL | Anavex Life Sciences Corp… | $4.43 | 410.54M | — | — | — | — | -8.09 | 3.96 | — | -5.88 | -210.39 | 3.96 | 0.00% | — | — | -43.11% | 523.72% | -38.75% | 0.00 | — | 11.60 | 11.56 | 2.21 | 385.00% | — | 2672.00% | -10.40% | -4.36 | 397.76% | 0.00% | 0.00% | 0.00% | -5.30 | -6.98 | — | 19.47 |
| BFLY | Butterfly Network, Inc. | $3.79 | 957.36M | +668% | -29% | — | — | -12.35 | 4.85 | 9.75 | -12.15 | — | 5.05 | 46.85% | -88.53% | -78.95% | -42.25% | -104.05% | -27.89% | 0.09 | -58.00 | 3.83 | 2.72 | 1.97 | -882.00% | 1896.00% | -6386.00% | -1.69% | -0.20 | -19.32% | 0.00% | 0.00% | 7.02% | -9.47 | -51.01 | 8.39 | 1.64 |
| CLPT | ClearPoint Neuro, Inc. | $12.57 | 373.94M | +192% | -56% | — | — | -18.68 | 13.91 | 11.25 | -18.87 | — | 14.18 | 60.92% | -62.91% | -60.25% | -81.24% | -189.62% | -46.22% | 0.14 | — | 3.22 | 2.40 | 0.93 | -2222.00% | 3104.00% | -3610.00% | -2.61% | -0.86 | -88.59% | 0.00% | 0.00% | 2.08% | -17.05 | -36.50 | 10.73 | 8.37 |
| INNV | InnovAge Holding Corp. | $8.96 | 1.22B | +275% | -51% | -93% | — | -14.52 | 2.18 | 0.60 | 151.10 | -38.72 | 5.76 | 68.50% | -3.49% | -3.55% | -14.02% | -11.68% | -6.22% | 0.43 | -6.45 | 1.07 | 0.88 | 10.98 | 3750.00% | 1176.00% | -15937.00% | 5.18% | 0.20 | 10.44% | 0.00% | 0.00% | 5.16% | -17.08 | 19.11 | 0.60 | 2.17 |
| OFIX | Orthofix Medical Inc. | $13.53 | 535.78M | +193% | -60% | — | — | — | 1.18 | 0.65 | -30.45 | — | 2.92 | 67.09% | -8.33% | -11.21% | 0.00% | -11.44% | 0.00% | 0.51 | -3.92 | 2.45 | 1.28 | -6.59 | -3091.00% | 285.00% | -8592.00% | -0.24% | 0.20 | -0.21% | 0.00% | — | 0.00% | -9.94 | -532.03 | 0.83 | 1.24 |
| PACB | Pacific Biosciences of Ca… | $1.68 | 507.2M | +1,311% | -61% | — | — | -0.89 | 90.85 | 3.04 | -28.24 | -1.27 | -1.48 | 31.67% | -348.46% | -341.47% | -213.45% | -87.50% | -53.45% | 141.98 | -80.18 | 6.89 | 5.79 | -14.03 | 7009.00% | 389.00% | -4633.00% | -23.44% | -2.04 | -17.88% | 0.00% | 0.00% | 28.22% | -1.73 | -8.48 | 6.04 | -1.28 |
| VREX | Varex Imaging Corporation | $13.17 | 552.08M | +77% | -64% | — | — | -6.94 | 1.03 | 0.57 | 209.03 | -15.31 | 1.86 | 34.39% | -3.29% | -8.32% | -13.87% | -3.65% | -6.01% | 0.85 | -0.78 | 3.43 | 1.67 | 73.40 | 4530.00% | 414.00% | -784.00% | 3.88% | 0.22 | 2.47% | 0.00% | 0.00% | 9.24% | -26.32 | 38.91 | 0.87 | 1.63 |
About SI-BONE, Inc.
SI-BONE, Inc., a medical device company, develops implantable devices used to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. It offers iFuse, a minimally invasive surgical implant system to address sacroiliac joint dysfunction and degeneration, adult deformity, and pelvic ring traumatic fractures. The company also provides iFuse-3D, a titanium implant that combines the triangular cross-section of the iFuse implant with the proprietary 3D-printed porous surface and fenestrated design; and iFuse-TORQ, a set of 3D-printed threaded implants designed to treat fractures of the pelvis and for minimally invasive sacroiliac joint fusion. It markets its products primarily with a direct sales force, as well as through distributors. The company was incorporated in 2008 and is headquartered in Santa Clara, California.
- CEO
- Laura A. Francis
- Employees
- 349
- Beta
- 0.68
Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Upside computed as ($22.29 ÷ $13.21) − 1 = +68.74% (DCF, example).